Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Press releases

PRESS RELEASE

published on 10/01/2024 at 17:46, 1 year 11 months ago

HBM Healthcare Investments posts half-year profit of CHF 23 million for 2024/2025 financial year; currency effects had a strong negative impact on the result
HBM Healthcare Investments AG reports CHF 23 million profit in 2024/2025 first half, impacted by negative currency effects. NAV per share and share price increased

HBM Healthcare Investments Financial Year Currency Effects Profit NAV Increase
PRESS RELEASE

published on 10/01/2024 at 17:45, 1 year 11 months ago

R&S Group warrants converted by 79%
R&S Group Holding AG announces 79% conversion of warrants, strengthening equity and liquidity by CHF 60.8 million. Total of 5,294,098 warrants converted to registered shares

Liquidity SIX Swiss Exchange R&S Group Equity Warrants Conversion
PRESS RELEASE

published on 10/01/2024 at 17:45, 1 year 11 months ago

Déclaration relative au nombre total de droits de vote et d'actions au 30 septembre 2024
Agripower, intégrateur de solutions de méthanisation, leader français sur ses marchés, réalise un CA de 6M€ en 2022-2023. Informations financières conformes à la réglementation boursière

Chiffre D'affaires Règlementation Boursière Méthanisation Agripower Leaders Français
REGULATED PRESS RELEASE

published on 10/01/2024 at 17:30, 1 year 11 months ago

Evolution mensuelle du 30 septembre 2024
Communiqué de presse sur l'évolution mensuelle du nombre de droits de vote et d'actions de la société Mr.Bricolage au 30 septembre 2024

Droits De Vote Actions Évolution Mensuelle Mr.Bricolage Finances
PRESS RELEASE

published on 10/01/2024 at 17:30, 1 year 11 months ago

Thousands Flock to Alabama for One of the Nation’s Quirkiest Winter and Ski Events - Even Without Snow
Unclaimed Baggage's 43rd Annual Ski Sale Event in Scottsboro, Alabama draws winter gear enthusiasts nationwide with unbeatable shopping deals. Event features top brands at discounted prices, eco-friendly initiatives, and winter-themed activities

Eco-friendly Ski Sale Event Unclaimed Baggage Winter Gear Shopping Deals
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 year 11 months ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
PRESS RELEASE

published on 10/01/2024 at 17:17, 1 year 11 months ago

SMT Scharf AG requests change of stock ticker symbol
SMT Scharf AG requests change of stock ticker symbol from 'S4AA' to 'S188' effective October 02, 2024, for trading on Frankfurt Stock Exchange. Company specializes in underground mining transport solutions and logistics systems

Frankfurt Stock Exchange SMT Scharf AG Underground Mining Logistics Systems Stock Ticker Symbol
PRESS RELEASE

published on 10/01/2024 at 17:15, 1 year 11 months ago

Rollover Transaction Completed September 27, 2024
Maple Leaf Critical Minerals' Partnership completes rollover transaction transferring assets to Resource Mutual Fund. Investors receive Resource Mutual Fund shares

Investors Partnership Maple Leaf Critical Minerals Rollover Transaction Resource Mutual Fund
PRESS RELEASE

published on 10/01/2024 at 17:09, 1 year 11 months ago

EQS-Adhoc: Samara Asset Group p.l.c. contemplates to issue a EUR 30 million bond
Samara Asset Group p.l.c. considers issuing EUR 30 million bond to acquire Bitcoin and partnership stakes. Details to follow

Private Placement Bitcoin Samara Asset Group EUR 30 Million Bond Partnership Stakes
PRESS RELEASE

published on 10/01/2024 at 17:06, 1 year 11 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH releases an update on Formycon AG, with analyst Simon Scholes reiterating a BUY rating and raising the price target from EUR 80 to EUR 82. The approval of the biosimilar FYB202 in the EU and US contributes to the positive outlook on Formycon's market share prospects

Investment Recommendation Formycon AG First Berlin Equity Research GmbH FYB202 Approval Biosimilar Market

Accesswire

Published on 09/12/2026 at 02:35, 15 hours 4 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 39 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 34 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 20 hours 14 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 10 hours 9 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 19 hours 24 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 29 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 55 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 23 hours 24 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 10 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 10 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 10 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 10 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 22 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE